Fondo Italiano FIPEC makes co-investment in Adler Ortho alongside Andera Partners

PUBT · 1d ago
Fondo Italiano FIPEC makes co-investment in Adler Ortho alongside Andera Partners
  • Fondo Italiano d'Investimento SGR made four new minority co-investments via FIPEC in Adler Ortho, Costa Edutainment, Genetic, DMX Pharma.
  • Transactions lift FIPEC’s portfolio to 11 deals since early 2024; about 65% of the fund’s EUR 115 million commitments deployed.
  • Adler Ortho investment alongside Andera Partners targets US expansion following FDA approvals, supported by 2025 revenue of about EUR 70 million.
  • Costa Edutainment deal alongside Nextalia Private Equity backs growth, with Ponte Ter retaining a 30% stake; 2025 revenue about EUR 78 million.
  • Genetic co-investment with Renaissance Partners, Pavese family supports capacity expansion; DMX Pharma co-lead with The Club Dealers, Azzurra Capital targets international growth.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fondo Italiano d'Investimento SGR S.p.A. published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.